Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
6.64
+0.01 (0.23%)
At close: Jan 16, 2026, 4:00 PM EST
6.77
+0.13 (2.03%)
After-hours: Jan 16, 2026, 5:37 PM EST
IMDX Market Cap
IMDX has a market cap or net worth of $190.19 million as of January 16, 2026. Its market cap has increased by 374.29% in one year.
Market Cap
190.19M
Enterprise Value
174.62M
1-Year Change
374.29%
Ranking
Category
Stock Price
$6.64
Market Cap Chart
Since January 4, 2016, IMDX's market cap has decreased from $228.70M to $190.19M, a decrease of -16.84%. That is a compound annual growth rate of -1.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 190.20M | -11.53% |
| Dec 31, 2025 | 215.00M | 436.16% |
| Dec 31, 2024 | 40.10M | 93.72% |
| Dec 29, 2023 | 20.70M | -45.67% |
| Dec 30, 2022 | 38.10M | -80.96% |
| Dec 31, 2021 | 200.10M | 24.52% |
| Dec 31, 2020 | 160.70M | 37.47% |
| Dec 31, 2019 | 116.90M | 108.38% |
| Dec 31, 2018 | 56.10M | -61.60% |
| Dec 29, 2017 | 146.10M | -27.82% |
| Dec 30, 2016 | 202.40M | -11.50% |
| Jan 4, 2016 | 228.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |